182 related articles for article (PubMed ID: 24874530)
1. Orbital lymphoproliferative disorders (OLPDs): value of MR imaging for differentiating orbital lymphoma from benign OPLDs.
Haradome K; Haradome H; Usui Y; Ueda S; Kwee TC; Saito K; Tokuuye K; Matsubayashi J; Nagao T; Goto H
AJNR Am J Neuroradiol; 2014 Oct; 35(10):1976-82. PubMed ID: 24874530
[TBL] [Abstract][Full Text] [Related]
2. Benign and malignant orbital lymphoproliferative disorders: Differentiating using multiparametric MRI at 3.0T.
Xu XQ; Hu H; Liu H; Wu JF; Cao P; Shi HB; Wu FY
J Magn Reson Imaging; 2017 Jan; 45(1):167-176. PubMed ID: 27299917
[TBL] [Abstract][Full Text] [Related]
3. Orbital benign and malignant lymphoproliferative disorders: Differentiation using semi-quantitative and quantitative analysis of dynamic contrast-enhanced magnetic resonance imaging.
Hu H; Xu XQ; Liu H; Hong XN; Shi HB; Wu FY
Eur J Radiol; 2017 Mar; 88():88-94. PubMed ID: 28189215
[TBL] [Abstract][Full Text] [Related]
4. Indeterminate orbital masses: restricted diffusion at MR imaging with echo-planar diffusion-weighted imaging predicts malignancy.
Sepahdari AR; Aakalu VK; Setabutr P; Shiehmorteza M; Naheedy JH; Mafee MF
Radiology; 2010 Aug; 256(2):554-64. PubMed ID: 20656840
[TBL] [Abstract][Full Text] [Related]
5. Orbital masses: the usefulness of diffusion-weighted imaging in lesion categorization.
Fatima Z; Ichikawa T; Ishigame K; Motosugi U; Waqar AB; Hori M; Iijima H; Araki T
Clin Neuroradiol; 2014 Jun; 24(2):129-34. PubMed ID: 23846020
[TBL] [Abstract][Full Text] [Related]
6. The value of contrast-enhanced dynamic and diffusion-weighted MR imaging for distinguishing benign and malignant splenic masses.
Choi SY; Kim SH; Jang KM; Kang TW; Song KD; Moon JY; Choi YH; Lee BR
Br J Radiol; 2016 Jul; 89(1063):20160054. PubMed ID: 27164031
[TBL] [Abstract][Full Text] [Related]
7. Imaging of orbital lymphoproliferative disorders.
Valvassori GE; Sabnis SS; Mafee RF; Brown MS; Putterman A
Radiol Clin North Am; 1999 Jan; 37(1):135-50, x-xi. PubMed ID: 10026734
[TBL] [Abstract][Full Text] [Related]
8. Histogram analysis of dynamic contrast-enhanced magnetic resonance imaging for differentiating malignant from benign orbital lymphproliferative disorders.
Xu XQ; Qian W; Hu H; Su GY; Liu H; Shi HB; Wu FY
Acta Radiol; 2019 Feb; 60(2):239-246. PubMed ID: 29804475
[TBL] [Abstract][Full Text] [Related]
9. Ocular adnexal lymphoma: diffusion-weighted mr imaging for differential diagnosis and therapeutic monitoring.
Politi LS; Forghani R; Godi C; Resti AG; Ponzoni M; Bianchi S; Iadanza A; Ambrosi A; Falini A; Ferreri AJ; Curtin HD; Scotti G
Radiology; 2010 Aug; 256(2):565-74. PubMed ID: 20656841
[TBL] [Abstract][Full Text] [Related]
10. Dynamic contrast-enhanced MRI in orbital lymphoproliferative disorders: Effects of region of interest selection methods on time efficiency, measurement reproducibility, and diagnostic ability.
Qian W; Xu XQ; Hu H; Su GY; Wu JF; Shi HB; Wu FY
J Magn Reson Imaging; 2018 May; 47(5):1298-1305. PubMed ID: 28922524
[TBL] [Abstract][Full Text] [Related]
11. Improving diagnostic performance of differentiating ocular adnexal lymphoma and idiopathic orbital inflammation using intravoxel incoherent motion diffusion-weighted MRI.
Jiang H; Wang S; Li Z; Xie L; Wei W; Ma J; Xian J
Eur J Radiol; 2020 Sep; 130():109191. PubMed ID: 32745898
[TBL] [Abstract][Full Text] [Related]
12. Orbital malignant lesions in adults: multiparametric MR imaging.
Sun B; Song L
Jpn J Radiol; 2017 Aug; 35(8):454-462. PubMed ID: 28550356
[TBL] [Abstract][Full Text] [Related]
13. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T.
Doskaliyev A; Yamasaki F; Ohtaki M; Kajiwara Y; Takeshima Y; Watanabe Y; Takayasu T; Amatya VJ; Akiyama Y; Sugiyama K; Kurisu K
Eur J Radiol; 2012 Feb; 81(2):339-44. PubMed ID: 21129872
[TBL] [Abstract][Full Text] [Related]
14. Orbital Indeterminate Lesions in Adults: Combined Magnetic Resonance Morphometry and Histogram Analysis of Apparent Diffusion Coefficient Maps for Predicting Malignancy.
Xu XQ; Hu H; Su GY; Zhang L; Liu H; Hong XN; Shi HB; Wu FY
Acad Radiol; 2016 Feb; 23(2):200-8. PubMed ID: 26625705
[TBL] [Abstract][Full Text] [Related]
15. Characterization of orbital masses by multiparametric MRI.
Ro SR; Asbach P; Siebert E; Bertelmann E; Hamm B; Erb-Eigner K
Eur J Radiol; 2016 Feb; 85(2):324-36. PubMed ID: 26781137
[TBL] [Abstract][Full Text] [Related]
16. Lymphoproliferative disease of the orbit.
Weber AL; Jakobiec FA; Sabates NR
Neuroimaging Clin N Am; 1996 Feb; 6(1):93-111. PubMed ID: 8919136
[TBL] [Abstract][Full Text] [Related]
17. MRI of Pediatric Orbital Masses: Role of Quantitative Diffusion-weighted Imaging in Differentiating Benign from Malignant Lesions.
Jaju A; Rychlik K; Ryan ME
Clin Neuroradiol; 2020 Sep; 30(3):615-624. PubMed ID: 31134316
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Utility of Diffusion-Weighted Imaging and Apparent Diffusion Coefficient for Common Orbital Lesions: A Review.
Cameron CA; Tong JY; Juniat V; Patel S; Selva D
Ophthalmic Plast Reconstr Surg; 2022 Nov-Dec 01; 38(6):515-521. PubMed ID: 34798654
[TBL] [Abstract][Full Text] [Related]
19. Differentiating benign and malignant inflammatory breast lesions: Value of T2 weighted and diffusion weighted MR images.
Kanao S; Kataoka M; Iima M; Ikeda DM; Toi M; Togashi K
Magn Reson Imaging; 2018 Jul; 50():38-44. PubMed ID: 29545213
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotypic profiles for distinguishing orbital mucosa-associated lymphoid tissue lymphoma from benign lymphoproliferative tumors.
Ueda S; Usui Y; Nagai T; Diaz-Aguilar D; Nagao T; Goto H
Jpn J Ophthalmol; 2017 Jul; 61(4):354-360. PubMed ID: 28421369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
